IL-6's Role in Lung Inflammation and Remodeling
Author Information
Author(s): Pedroza Mesias, Schneider Daniel J., Karmouty-Quintana Harry, Coote Julie, Shaw Stevan, Corrigan Rebecca, Molina Jose G., Alcorn Joseph L., Galas David, Gelinas Richard, Blackburn Michael R.
Primary Institution: University of Texas Medical School at Houston
Hypothesis
IL-6 signaling contributes to tissue destruction and remodeling in a model of chronic lung disease where adenosine levels are elevated.
Conclusion
Blocking IL-6 signaling during chronic stages of disease may provide benefit in halting remodeling processes such as fibrosis and air-space destruction.
Supporting Evidence
- IL-6 levels were elevated in the lungs of ADA-deficient mice.
- Neutralizing IL-6 reduced pulmonary inflammation and fibrosis.
- IL-6 neutralization decreased airway remodeling in mice.
- Blocking IL-6 signaling led to reduced STAT-3 activation in the lungs.
Takeaway
This study shows that a protein called IL-6 makes lung diseases worse, and stopping it might help people with these diseases feel better.
Methodology
The study used ADA-deficient mice to test the effects of neutralizing IL-6 on lung inflammation and remodeling.
Statistical Information
P-Value
p≤0.05
Statistical Significance
p≤0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website